Ann Pediatr Endocrinol Metab.  2012 Jun;17(2):82-91. 10.6065/apem.2012.17.2.82.

Childhood Onset Pituitary Adenoma: Clinical Presentations and Outcomes of 24 Cases

Affiliations
  • 1Department of Pediatrics, Seoul National University College of Medicine, Seoul, Korea. growth@snu.ac.kr

Abstract

PURPOSE
Our purpose was to evaluate the clinical presentations at diagnosis and treatment outcomes of functional pituitary adenoma (PA) and nonfunctional PAs (NFPA) in childhood and adolescence.
METHODS
We performed a retrospective review of the medical records of patients diagnosed with PA before 18 years of age.
RESULTS
The mean age at diagnosis of 24 patients (9 males, 15 females) was 12.3 years, and the mean follow-up period was 4.5 years. PAs were categorized as follows: prolactinoma (n=7, 29.2%), adrenocorticotropic hormone secreting adenomas (n=4, 16.7%), growth hormone secreting adenomas (n=3, 12.5%), and NFPAs (n=10, 41.7%). The proportion of macroadenoma (n=13, 54.2%) was similar to that of microadenoma (n=11, 45.8%). Sixteen patients (66.7%) who were diagnosed with functional PA (including all prolactinomas), and two NFPAs underwent surgery due to mass effects. The patients who received surgery had a higher risk for hypopituitarism than those who did not (75.0% vs. 12.5%; P =0.008). Recurrence occurred in five patients, all of whom had residual tumors after surgery for macroadenoma. The degree of obesity at latest follow-up was associated with that at diagnosis (P <0.001).
CONCLUSION
The prevalence of NFPAs was higher than that of previous reports, which was explained by higher detection of incidentalomas. Prolactinoma was the most common functional PA. Thorough investigation of symptoms related to hormone excess and hormone profiles is important for differential diagnosis and decision regarding treatment plan. Additionally, the regular follow up for relapse and endocrine deficit is mandatory in patients with PA, especially those who had received pituitary surgery.

Keyword

Pituitary neoplasms; Child; Adolescent

MeSH Terms

Adenoma
Adolescent
Adrenocorticotropic Hormone
Child
Diagnosis, Differential
Follow-Up Studies
Growth Hormone
Humans
Hypopituitarism
Male
Medical Records
Neoplasm, Residual
Obesity
Pituitary Neoplasms
Prevalence
Prolactinoma
Recurrence
Retrospective Studies
Adrenocorticotropic Hormone
Growth Hormone
Full Text Links
  • APEM
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr